| Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid M Bačkorová, M Bačkor, J Mikeš, R Jendželovský, P Fedoročko Toxicology in vitro 25 (1), 37-44, 2011 | 229 | 2011 |
| Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines M Bačkorová, R Jendželovský, M Kello, M Bačkor, J Mikeš, P Fedoročko Toxicology in vitro 26 (3), 462-468, 2012 | 214 | 2012 |
| Hypericin in the Light and in the Dark: Two Sides of the Same Coin Z Jendželovská, R Jendželovský, B Kuchárová, P Fedoročko Frontiers in plant science 7, 560, 2016 | 183 | 2016 |
| Potency of non-steroidal anti-inflammatory drugs in chemotherapy L Hiľovská, R Jendželovský, P Fedoročko Molecular and clinical oncology 3 (1), 3-12, 2015 | 90 | 2015 |
| Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells R Jendželovský, J Mikeš, K Souček, J Procházková, M Kello, V Sačková, ... Photochemical & Photobiological Sciences 8 (12), 1716-1723, 2009 | 75 | 2009 |
| 3, 6-Bis (3-alkylguanidino) acridines as DNA-intercalating antitumor agents J Plsikova, L Janovec, J Koval, J Ungvarsky, J Mikes, R Jendzelovsky, ... European journal of medicinal chemistry 57, 283-295, 2012 | 51 | 2012 |
| Anticancer and immunomodulatory effects of Lactobacillus plantarum LS/07, inulin and melatonin in NMU-induced rat model of breast cancer M Kassayova, N Bobrov, L Strojný, P Orendáš, V Demečková, ... Anticancer research 36 (6), 2719-2728, 2016 | 50 | 2016 |
| Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds J Janočková, J Plšíková, J Kašpárková, V Brabec, R Jendželovský, ... European Journal of Pharmaceutical Sciences 76, 192-202, 2015 | 49 | 2015 |
| Single pre-treatment with hypericin, a St. John’s wort secondary metabolite, attenuates cisplatin-and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells Z Jendželovská, R Jendželovský, L Hiľovská, J Kovaľ, J Mikeš, ... Toxicology in Vitro 28 (7), 1259-1273, 2014 | 45 | 2014 |
| The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells M Šemeláková, J Mikeš, R Jendželovský, P Fedoročko Journal of Photochemistry and Photobiology B: Biology 117, 115-125, 2012 | 41 | 2012 |
| Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A A Halaburková, R Jendželovský, J Kovaľ, Z Herceg, P Fedoročko, ... Clinical epigenetics 9, 1-16, 2017 | 39 | 2017 |
| Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats T Kisková, R Jendželovský, E Rentsen, A Maier-Salamon, N Kokošová, ... European Journal of Cancer Prevention 23 (6), 506-513, 2014 | 39 | 2014 |
| The role of p53 in the efficiency of photodynamic therapy with hypericin and subsequent long-term survival of colon cancer cells J Mikeš, J Koval’, R Jendželovský, V Sačková, I Uhrinová, M Kello, ... Photochemical & Photobiological Sciences 8, 1558-1567, 2009 | 39 | 2009 |
| Flow cytometric determination of 5-bromo-2ʹ-deoxyuridine pharmacokinetics in blood serum after intraperitoneal administration to rats and mice A Matiašová, J Ševc, J Mikeš, R Jendželovský, Z Daxnerová, P Fedoročko Histochemistry and cell biology 142, 703-712, 2014 | 37 | 2014 |
| Tacrine derivatives as dual topoisomerase I and II catalytic inhibitors J Janočková, J Plšíková, R Jendželovský, J Mikeš, J Kašpárková, ... Bioorganic Chemistry 59, 168-176, 2015 | 36 | 2015 |
| New spiro tria (thia) zolidine⿿ acridines as topoisomerase inhibitors, DNA binders and cytostatic compounds OM Salem, M Vilková, J JanoĿková, R Jendželovský, P FedoroĿko, ... International journal of biological macromolecules 86, 690-700, 2016 | 35 | 2016 |
| PUFAs enhance oxidative stress and apoptosis in tumour cells exposed to hypericin-mediated PDT M Kello, J Mikeš, R Jendželovský, J Kovaľ, P Fedoročko Photochemical & Photobiological Sciences 9 (9), 1244-1251, 2010 | 33 | 2010 |
| Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy R Jendželovský, Z Jendželovská, B Kucharova, P Fedoročko Biomedicine & Pharmacotherapy 109, 2173-2181, 2019 | 32 | 2019 |
| Degradation of HER2 receptor through hypericin‐mediated photodynamic therapy J Kovaľ, J Mikeš, R Jendželovský, M Kello, P Solár, P Fedoročko Photochemistry and photobiology 86 (1), 200-205, 2010 | 28 | 2010 |
| Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells M Šemeláková, R Jendželovský, P Fedoročko Biomedicine & Pharmacotherapy 81, 38-47, 2016 | 26 | 2016 |
